Wendy Walwyn

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

Kabirullah Lutfy, Shoshana Eitan, Camron D. Bryant et al. · PubMed · 2003 · 220 citations

Pain Medicine, Molecular Pain, Orl-1 Receptor Antagonist +19

Buprenorphine-Induced Antinociception Is Mediated by μ-Opioid Receptors and Compromised by Concomitant Activation of Opioid Receptor-Like Receptors

Kabirullah Lutfy, Shoshana Eitan, Camron D. Bryant et al. · Journal of Neuroscience · 2003 · 213 citations · Full text

Pain Disorders, Pain Medicine, Molecular Pain +20

Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α‐synuclein

Hoa A. Lam, Nanping Wu, Ingrid Cely et al. · Journal of Neuroscience Research · 2011 · 200 citations · Full text

Synaptic Transmission, Neurotransmitter, Dopamine Loss +24

Targeted expression of μ-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward

Yijun Cui, Sean B. Ostlund, Alex S. James et al. · Nature Neuroscience · 2014 · 154 citations · Full text

Striatal Direct-pathway Neurons, Synaptic Plasticity, Addiction +11

Ligand-Directed Trafficking of the δ-Opioid Receptor<i>In Vivo</i>: Two Paths Toward Analgesic Tolerance

Amynah Pradhan, Wendy Walwyn, Chihiro Nozaki et al. · Journal of Neuroscience · 2010 · 130 citations · Full text